Authors
Latest:
Balancing Family With Career Goals During an Oncology FellowshipSuccessfully attaining our goals in fellowship is demanding. They are accomplished by establishing work/life balance.
Latest:
Dr. Pennell on the Economic Impact of Next-Generation SequencingNathan Pennell, MD, PhD, director, Lung Cancer Medical Oncology Program, Cleveland Clinic Taussig Cancer Institute, discusses the economic impact of next-generation sequencing.
Latest:
Dr Daver on the Evolution of Survivorship and Treatment Outcomes in AMLNaval G. Daver, MD, discusses the evolution of survivorship in patients with acute myeloid leukemia.
Latest:
Dr Daver on the Potential Utility of Uproleselan in R/R AMLNaval G. Daver, MD, discusses the potential utility of uproleselan in relapsed/refractory acute myeloid leukemia.
Latest:
Dr Daver on the Potential Role of MRD Assessment in AML TreatmentNaval G. Daver, MD, discusses the potential role of minimal residual disease assessments in acute myeloid leukemia.
Latest:
Navigating Treatment Options for Patients With Early-Stage Breast CancerGenetic advances have helped elucidate the heterogenous nature of breast cancer, however optimal strategies for patients with early-stage disease still need to be ironed out.
Latest:
Dr. Naveed Zafar Janjua on Impact of Hepatitis C Treatment Timing on HCC RiskNaveed Zafar Janjua, MBBS, MSc, DrPH, senior scientist, clinical prevention services, BC Centre for Disease Control and clinical associate professor, School of Population and Public Health, University of British Columbia, discusses the findings from the British Columbia hepatitis testers cohort, which looked at the impact of hepatitis infection on long term risk of hepatocellular carcinoma (HCC).
Latest:
Exploring the Future of MF TreatmentThe panel closes their discussion by highlighting novel agents in the treatment of myeloproliferative neoplasms to look out for.
Latest:
Dr. Sharma on Tolerability of SIRT in Patients With CRCDr. Navesh K. Sharma, associate professor of Radiology in the Division of Radiology and Oncology at Penn State Hershey Medical Center and section chief of Radiation Oncology at the Penn State Health St. Joseph Cancer Center, discusses the safety profile of selective internal radiation therapy (SIRT) when added to chemotherapy for patients with colorectal cancer (CRC) that has metastasized to the liver.
Latest:
ARPI-Based Combination Regimens – CONTACT-02 (Cabozantinib plus atezolizumab)Panelists discuss how the CONTACT-02 trial highlights the potential of cabozantinib combined with atezolizumab in improving treatment outcomes for patients with advanced cancer.
Latest:
Understanding Efficacy, Safety, and PSA Kinetics of Apalutamide Plus ADT in Patients With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)Sponsored Content: Neal Shore, MD, FACS reviews new data on the TITAN trial of apalutamide in patients with mCSPC.
Latest:
The Role of Positive Quality InterventionsNeal Dave, PharmD, Texas Oncology, discusses the role of positive quality interventions (PQI).
Latest:
Dr. Ready on Leveraging Nivolumab/Ipilimumab Plus Chemotherapy in NSCLCNeal Edward Ready, MD, PhD, discusses factors to consider when deciding when the use the regimen of nivolumab and ipilimumab plus chemotherapy in metastatic non–small cell lung cancer.
Latest:
Dr. Weinreb on the Different Roles in a Gaucher DiagnosisDr. Neal Weinreb, from University Research Foundation for Lysosomal Storage Diseases, on the Different Roles in a Gaucher Diagnosis
Latest:
Treatment Patterns of Metastatic Triple-Negative Breast Cancer in US Community Practice SettingsFirst-line treatment patterns for metastatic triple-negative breast cancer are diverse, reflecting a lack of consensus and an unmet need for standardized therapy.
Latest:
Dr Shore on the Rationale for the Duravelo-2 Trial in Metastatic Urothelial CancerNeal D. Shore, MD, FACS, discusses the Duravelo-1 and Duravelo-2 trials investigating zelenectide pevedotin in metastatic urothelial carcinoma.
Latest:
Dr. Young on Eltrombopag Added to Immunosuppression for Patients With Aplastic AnemiaNeal Young, MD, senior investigator, Cell Biology Section, National Heart, Lung, and Blood Institute, National Institute of Health, discusses a study that examined the efficacy of eltrombopag when added to standard immunosuppression for patients with aplastic anemia.
Latest:
Dr. Parikh on Future Research Directions in Hepatitis C-Related HCCNeehar Parikh, MD, discusses future research directions in hepatitis C-related hepatocellular carcinoma.
Latest:
Dr. Denduluri on Treatment Approaches in Early-Stage HR+/HER2- Breast CancerNeelima Denduluri, MD, shares treatment approaches in patients with early-stage hormone receptor-positive, HER2-negative breast cancer.
Latest:
Key Takeaways on Updates in Bladder CancerElizabeth Plimack, MD, MS, FASCO, recaps the discussion with key takeaways on recent updates in bladder cancer.
